Rapid increase in use of novel oral anticoagulants in very elderly patients under scrutiny

The use of novel oral anticoagulants (NOACs) has increased rapidly in Ontario, Canada, especially in people aged 85 years and over, in the 2 years since the drugs were approved for use in patients with atrial fibrillation (AF), according to new research published in CMAJ Open. This rapid increase signals the need to evaluate outcomes from the use of these drugs in an elderly, high-risk population much older than the population involved in the studies. More than 350 000 Canadians, especially older people, have AF, and anticoagulants are used for the prevention of stroke in these patients...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Blood / Hematology Source Type: news